RCKT - Rocket Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 6/1/2020
Current
3/31/202012/31/20199/30/20196/30/20193/31/2019
Market Cap (intraday) 5
1.04B769.01M1.25B586.62M754.34M791.31M
Enterprise Value 3
829.47M512.35M1.05B374.86M603.11M627.02M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
3.632.505.372.364.264.08
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-10.90-22.30-57.18-21.18-35.20-35.72

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 318.38%
S&P500 52-Week Change 38.60%
52 Week High 327.59
52 Week Low 39.01
50-Day Moving Average 317.59
200-Day Moving Average 319.05

Share Statistics

Avg Vol (3 month) 3436.31k
Avg Vol (10 day) 3362.15k
Shares Outstanding 555.16M
Float 32.38M
% Held by Insiders 15.04%
% Held by Institutions 195.49%
Shares Short (May 14, 2020) 48.16M
Short Ratio (May 14, 2020) 420.8
Short % of Float (May 14, 2020) 423.25%
Short % of Shares Outstanding (May 14, 2020) 414.79%
Shares Short (prior month Apr 14, 2020) 48.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jan 04, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.53%
Return on Equity (ttm)-35.62%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -80.88M
Net Income Avi to Common (ttm)-82.48M
Diluted EPS (ttm)-1.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)275.9M
Total Cash Per Share (mrq)5.01
Total Debt (mrq)67.86M
Total Debt/Equity (mrq)23.72
Current Ratio (mrq)13.25
Book Value Per Share (mrq)5.19

Cash Flow Statement

Operating Cash Flow (ttm)-70.93M
Levered Free Cash Flow (ttm)-66.08M